The Competitive Generic Therapy designation looks to encourage the development of alternatives for drugs with inadequate generic competition. The Food and Drug Administration on Wednesday approved a ...

Defining the steps involved in a successful technology transfer process would benefit biopharma, say the researchers behind a “generic” blueprint intended to help drug makers move more easily from ...

Accelerate innovation through process-level implementation of AI. Increase agility; cut cycle times; improve organizational ...

The Global Generic Drugs Market is valued at USD 487.21 Billion in 2024 and is projected to reach a value of USD 898 Billion by 2035 at a CAGR (Compound Annual Growth Rate) of 5.75% between 2025 and ...

As the first biotech drugs begin to lose patent protection in the next few years, the US biotechnology industry is beginning to fear it will soon face price-cutting generic competition. Unlike the ...

Striking the right regulatory balance for pharmaceuticals is no easy task. On the one hand, policy should promote drug affordability by encouraging robust competition. On the other hand, policy should ...

To advance policies that secure the future of a leading U.S. innovative industry, it is important in this instance to gain a deeper understanding of what generic drugs are, what the FTC is challenging ...

The drugmaker Teva Pharmaceuticals made history in June by launching the first-ever generic version of a GLP-1 diabetes drug. This revolutionary class of medications, which are also growing ...

In the coming months, Congress will continue the important work of balancing the need for new cures with the need for affordable medicines. New litigation schemes, like the one in the CREATES Act, are ...

In the ever-evolving landscape of modern business, the pressure to innovate is relentless. Organizations are constantly pushed to develop state-of-the-art products, services, and business models that ...